Get the Stockscreener App
7.97
3.28%
-0.27
After Hours:
7.97
Alvotech stock is traded at $7.97, with a volume of 272.71K.
It is down -3.28% in the last 24 hours and down -0.75% over the past month.
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.
See More
Previous Close:
$8.24
Open:
$8.33
24h Volume:
272.71K
Relative Volume:
0.69
Market Cap:
$2.57B
Revenue:
$391.87M
Net Income/Loss:
$-441.45M
P/E Ratio:
-4.3081
EPS:
-1.85
Net Cash Flow:
$-301.21M
1W Performance:
-7.11%
1M Performance:
-0.75%
6M Performance:
-9.33%
1Y Performance:
-35.98%
1-Day Range:
$7.97
$8.347
1-Week Range:
$7.97
$8.96
52-Week Range:
$7.35
$13.70
Alvotech Stock (ALVO) Company Profile
Compare ALVO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALVO
Alvotech
|
7.97 | 2.57B | 391.87M | -441.45M | -301.21M | -1.85 |
|
ZTS
Zoetis Inc
|
142.26 | 62.54B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.72 | 43.30B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.08 | 40.08B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.02 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
440.06 | 19.90B | 3.08B | 1.24B | 1.07B | 25.61 |
Alvotech Stock (ALVO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-23-25 | Upgrade | Deutsche Bank | Hold → Buy |
| Feb-14-25 | Initiated | UBS | Buy |
| Jan-29-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Oct-20-23 | Upgrade | Citigroup | Sell → Neutral |
| Sep-21-23 | Initiated | Barclays | Equal Weight |
| Sep-07-22 | Initiated | Morgan Stanley | Equal-Weight |
| Sep-06-22 | Downgrade | Citigroup | Buy → Sell |
| Jul-26-22 | Initiated | Citigroup | Buy |
View All
Alvotech Stock (ALVO) Latest News
Chart based analysis of Alvotech trendsQuarterly Profit Report & Pattern Based Trade Signal System - newser.com
Will Alvotech Equity Warrant stock go up soonJuly 2025 Short Interest & Low Risk High Reward Ideas - newser.com
Volatility clustering patterns for Alvotech Equity WarrantTrade Exit Summary & Low Risk High Win Rate Picks - newser.com
Is Alvotech trending in predictive chart modelsOptions Play & High Accuracy Swing Trade Signals - newser.com
Best data tools to analyze Alvotech stockWeekly Risk Report & Reliable Intraday Trade Alerts - newser.com
Does Alvotech stock trade at a discount to peersWeekly Trend Recap & Community Trade Idea Sharing Platform - newser.com
Is Alvotech Equity Warrant stock supported by innovation pipelineEarnings Overview Report & AI Forecasted Entry and Exit Points - newser.com
Predicting Alvotech Equity Warrant trend using moving averages2025 Trading Volume Trends & Reliable Price Action Trade Plans - newser.com
Can Alvotech Equity Warrant stock outperform in 2025 bull marketMarket Movers & Real-Time Buy Zone Alerts - newser.com
Detecting price anomalies in Alvotech Equity Warrant with AISell Signal & Weekly Return Optimization Plans - newser.com
Backtesting results for Alvotech Equity Warrant trading strategiesJuly 2025 Technicals & Fast Momentum Stock Entry Tips - newser.com
Analyzing Alvotech with risk reward ratio chartsJuly 2025 Trends & Momentum Based Trading Ideas - newser.com
Comparing Alvotech Equity Warrant in custom built stock radarsJuly 2025 Big Picture & Low Risk High Win Rate Stock Picks - newser.com
Volume spikes in Alvotech stock – what they mean2025 Big Picture & High Conviction Buy Zone Picks - newser.com
Alvotech Equity Warrant stock trendline breakdownQuarterly Trade Review & High Win Rate Trade Tips - newser.com
What does recent volatility data suggest for AlvotechJuly 2025 Movers & Verified Chart Pattern Trade Signals - newser.com
Alvotech’s AVT23 Biosimilar Gains EMA Acceptance - MSN
Statistical indicators supporting Alvotech Equity Warrant’s strengthPortfolio Update Summary & Real-Time Chart Pattern Alerts - newser.com
How to read the order book for AlvotechJuly 2025 Price Swings & Capital Protection Trading Alerts - newser.com
Using Ichimoku Cloud for Alvotech technicalsCPI Data & Stock Market Timing Techniques - newser.com
Will Alvotech (Z45) stock beat revenue estimatesJuly 2025 Highlights & Growth Oriented Trade Recommendations - newser.com
Will Alvotech Equity Warrant stock benefit from green energy trendsJuly 2025 Catalysts & Safe Investment Capital Preservation Plans - newser.com
News impact scoring models applied to Alvotech Equity Warrant2025 Major Catalysts & Entry Point Confirmation Signals - newser.com
Alvotech Equity Warrant stock trend outlook and recovery path2025 Technical Patterns & Real-Time Buy Signal Notifications - newser.com
Alvotech's (ALVO) Sell (E+) Rating Reiterated at Weiss Ratings - MarketBeat
Here's How Alvotech is Expanding its Portfolio Beyond Immunology - MSN
Alvotech And Advanz Celebrate EU Omalizumab Filing - insights.citeline.com
European Marketing Application for AVT23, a Proposed Biosimilar to Xolair® (omalizumab), Accepted by the European Medicines Agency - Sahm
European Marketing Application for AVT23, a Proposed - GlobeNewswire
My Top 5 Biotech Stocks Big Pharma Could Buy Next - Seeking Alpha
ALVO: EMA Begins Review of AVT23; Advanz Holds Commercial Rights - Stock Titan
Will Alvotech Equity Warrant stock recover after recent dropBuy Signal & Momentum Based Trading Ideas - newser.com
EMA accepts application for Alvotech's AVT23 - Biostock
Advanz Pharma and Alvotech Announce EMA Acceptance of Marketing Application for Biosimilar AVT23 to Xolair® - Quiver Quantitative
Alvotech: EMA Accepts MAA for AVT23, biosimilar to Xolair | ALVO Stock News - Stock Titan
Real time breakdown of Alvotech Equity Warrant stock performanceQuarterly Profit Report & Daily Profit Focused Screening - newser.com
EMA Recommendations for AVT03 and Gobivaz Could Be a Game Changer for Alvotech (ALVO) - simplywall.st
Will Alvotech benefit from macro trendsTrade Exit Report & Verified Short-Term Trading Plans - newser.com
Visual analytics tools that track Alvotech performanceJuly 2025 News Drivers & Accurate Entry and Exit Point Alerts - newser.com
Can Alvotech Equity Warrant recover in the next quarterPortfolio Risk Report & Reliable Entry Point Alerts - newser.com
A Fresh Look at Alvotech (NasdaqGM:ALVO) Valuation as Investors Weigh Biotech Prospects - simplywall.st
A Fresh Look at Alvotech (NasdaqGM:ALVO) Valuation After Recent Stock Uptick - Yahoo Finance
Alvotech (NasdaqGM:ALVO): Is the Market Overlooking Its True Value? - simplywall.st
Alvotech Stock (ALVO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):